Alpha-adrenergic receptors and blood pressure control
- PMID: 2869681
- DOI: 10.1016/0002-9149(86)90716-2
Alpha-adrenergic receptors and blood pressure control
Abstract
Alpha-adrenergic receptors play an important role in the regulation of blood pressure (BP). There are 2 principal types of alpha receptors, alpha 1 and alpha 2, and both participate in circulatory control. Alpha 1 receptors are the classic postsynaptic alpha receptors and are found on vascular smooth muscle. They determine both arteriolar resistance and venous capacitance, and thus BP. Alpha 2 receptors are found both in the brain and in the periphery. In the brain stem, they modulate sympathetic outflow. Their function in the periphery is not yet fully understood, but they may contribute both to control of sympathetic tone and to local and regional blood flow. Drugs that enhance central alpha 2 activity, such as clonidine, guanfacine and the active metabolite of methyldopa, can significantly lower BP and are effective in the long-term control of hypertension, either alone or in combination with other drugs. While central alpha agonists, as a class, share a common pharmacologic mode of action, side effects, e.g., sedation and drowsiness, occur to different degrees with different drugs, and the individual agents also vary in terms of their propensity for causing withdrawal hypertension. The use of low-dose regimens or of newer drugs, such as guanfacine, with its longer half-life and duration of action, may reduce the likelihood of adverse reactions associated with this class of drugs.
Similar articles
-
The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.Hypertension. 1984 Sep-Oct;6(5 Pt 2):II28-33. doi: 10.1161/01.hyp.6.5_pt_2.ii28. Hypertension. 1984. PMID: 6094346 Review.
-
Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.Hypertension. 1984 Sep-Oct;6(5 Pt 2):II71-5. doi: 10.1161/01.hyp.6.5_pt_2.ii71. Hypertension. 1984. PMID: 6150002 Review.
-
Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.Am J Med. 1984 Oct 5;77(4A):17-25. doi: 10.1016/s0002-9343(84)80033-9. Am J Med. 1984. PMID: 6148891 Review.
-
Pharmacology of centrally acting hypotensive drugs.Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):13S-20S. doi: 10.1111/j.1365-2125.1980.tb04899.x. Br J Clin Pharmacol. 1980. PMID: 6104975 Free PMC article. Review.
-
Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):224-8. doi: 10.1097/00005344-198303000-00010. J Cardiovasc Pharmacol. 1983. PMID: 6188894
Cited by
-
Vasodilation and Blood Pressure-Lowering Effect of 3-Demethyl-2-Geranyl-4-Prenylbellidifoline, a Xanthone Obtained from Garcinia achachairu, in Hypertensive Rats.Plants (Basel). 2024 Feb 15;13(4):528. doi: 10.3390/plants13040528. Plants (Basel). 2024. PMID: 38498544 Free PMC article.
-
Trigeminal nerve stimulation: a current state-of-the-art review.Bioelectron Med. 2023 Dec 13;9(1):30. doi: 10.1186/s42234-023-00128-z. Bioelectron Med. 2023. PMID: 38087375 Free PMC article. Review.
-
Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist.Alcohol Clin Exp Res (Hoboken). 2023 Mar;47(3):432-434. doi: 10.1111/acer.15014. Epub 2023 Feb 28. Alcohol Clin Exp Res (Hoboken). 2023. PMID: 36852535 Free PMC article. No abstract available.
-
Role of adrenergic receptors in shock.Front Physiol. 2023 Jan 16;14:1094591. doi: 10.3389/fphys.2023.1094591. eCollection 2023. Front Physiol. 2023. PMID: 36726848 Free PMC article. Review.
-
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.Health Psychol Res. 2022 Nov 3;10(4):39576. doi: 10.52965/001c.39576. eCollection 2022. Health Psychol Res. 2022. PMID: 36425231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
